{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:44:35Z","timestamp":1778715875860,"version":"3.51.4"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2002,10,1]]},"DOI":"10.1038\/nrd914","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T20:57:04Z","timestamp":1034024224000},"page":"797-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":181,"title":["Toll-like receptors as potential therapeutic targets for multiple diseases"],"prefix":"10.1038","volume":"1","author":[{"given":"Claudia","family":"Zuany-Amorim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hastewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrd914_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway","year":"2002","unstructured":"Janeway, C. A. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197\u2013216 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrd914_CR2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","volume":"86","author":"B Lemaitre","year":"1996","unstructured":"Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M. & Hoffman, J. A. The dorsoventral regulatory gene cassette spatzle\/Toll\/cactus controls the potent antifugal response in Drosophila adults. Cell 86, 973\u2013983 (1996).","journal-title":"Cell"},{"key":"BFnrd914_CR3","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signalling in C3H\/Hej and C57BL\/10ScCr mice: mutations in TLR-4 gene. Science 282, 2085\u20132088 (1998).The first report to show that mammalian TLRs are involved in host defence.","journal-title":"Science"},{"key":"BFnrd914_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","volume":"1","author":"R Medzhitov","year":"2001","unstructured":"Medzhitov, R. Toll-like receptors and innate immunity. Nature Immunol. 1, 135\u2013145 (2001).","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0962-8924(01)02004-9","volume":"11","author":"JL Imler","year":"2001","unstructured":"Imler, J. L. & Hoffmann, J. A. Toll-like receptors in innate immunity. Trends Cell Biol. 11, 304\u2013311 (2001).","journal-title":"Trends Cell Biol."},{"key":"BFnrd914_CR6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2, 675\u2013680 (2001).","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR7","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino, K. et al. Cutting edge: Toll-like receptor-4 (TLR-4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR-4 as the LPS gene product. J. Immunol. 162, 3749\u20133752 (1999).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0952-7915(01)00304-1","volume":"14","author":"DM Underhill","year":"2002","unstructured":"Underhill, D. M. & Ozinsky, A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14, 103\u2013110 (2002).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrd914_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/86354","volume":"2","author":"C Wertz","year":"2001","unstructured":"Wertz, C. et al. Leptospiral lipopolysaccharide activates cells through a TLR-2-dependent mechanism. Nature Immunol. 2, 346\u2013352 (2001).","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/IAI.69.3.1477-1482.2001","volume":"69","author":"M Hirschfeld","year":"2001","unstructured":"Hirschfeld, M. et al. Signalling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69, 1477\u20131482 (2001).","journal-title":"Infect. Immun."},{"key":"BFnrd914_CR11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099\u20131103 (2001).","journal-title":"Nature"},{"key":"BFnrd914_CR12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi, H. et al. A Toll-like receptor recognises bacterial DNA. Nature 408, 740\u2013745 (2000).This study reports for the first time that bacterial DNA containing unmethylated CpG motifs binds to TLR-9 and has a direct immunomodulatory effect on immune cells  in vitro.","journal-title":"Nature"},{"key":"BFnrd914_CR13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou, L., Czopik-Holt, A., Medzhitov, R. & Flavell, R. Recognition of double stranded RNA and activation of NF\u03baB by Toll-like receptor 3. Nature 413, 696\u2013712 (2001).","journal-title":"Nature"},{"key":"BFnrd914_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4049\/jimmunol.169.1.10","volume":"169","author":"O Takeuchi","year":"2002","unstructured":"Takeuchi, O. et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10\u201314 (2002).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","volume":"2","author":"R Medzhitov","year":"1998","unstructured":"Medzhitov, R. et al. MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signalling pathways. Mol. Cell 2, 253\u2013258 (1998).","journal-title":"Mol. Cell"},{"key":"BFnrd914_CR16","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.271.5252.1128","volume":"271","author":"Z Cao","year":"1996","unstructured":"Cao, Z., Henzel, W. J. & Gao, X. IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128\u20131131 (1996).","journal-title":"Science"},{"key":"BFnrd914_CR17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/383443a0","volume":"383","author":"Z Cao","year":"1996","unstructured":"Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D. V. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443\u2013446 (1996).","journal-title":"Nature"},{"key":"BFnrd914_CR18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4049\/jimmunol.167.2.987","volume":"167","author":"Y Bulut","year":"2001","unstructured":"Bulut, Y., Faure, E., Thomas, L., Equils, O. & Arditi, M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167, 987\u2013994 (2001).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","volume":"413","author":"KA Fitzgerald","year":"2001","unstructured":"Fitzgerald, K. A. et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78\u201383 (2001).","journal-title":"Nature"},{"key":"BFnrd914_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1074-7613(00)80086-2","volume":"11","author":"T Kawai","year":"1999","unstructured":"Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115\u2013122 (1999).","journal-title":"Immunity"},{"key":"BFnrd914_CR21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1471-4906(02)02222-6","volume":"23","author":"LAJ O'Neill","year":"2002","unstructured":"O'Neill, L. A. J. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal. Trends Immunol. 23, 296\u2013300 (2002).","journal-title":"Trends Immunol."},{"key":"BFnrd914_CR22","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.4049\/jimmunol.166.9.5688","volume":"166","author":"T Kaisho","year":"2001","unstructured":"Kaisho, T., Takeuchi, O., Kawai, T., Hoshino, K. & Akira, S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166, 5688\u20135694 (2001).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0167-5699(97)01085-2","volume":"18","author":"JC Gutierrez-Ramos","year":"1997","unstructured":"Gutierrez-Ramos, J. C. & Bluethmann, H. Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol. Today 18, 329\u2013334 (1997).","journal-title":"Immunol. Today"},{"key":"BFnrd914_CR24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199703273361311","volume":"336","author":"HS Warren","year":"1997","unstructured":"Warren, H. S. Strategies for the treatment of sepsis. New Engl. J. Med. 336, 952\u2013953 (1997).","journal-title":"New Engl. J. Med."},{"key":"BFnrd914_CR25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.121.4.1329","volume":"121","author":"P Knuefermann","year":"2002","unstructured":"Knuefermann, P. et al. Cardiac inflammation and innate immunity in septic shock. Is there a role for Toll-like receptors? Chest 121, 1329\u20131336 (2002).","journal-title":"Chest"},{"key":"BFnrd914_CR26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/cc1471","volume":"6","author":"SM Opal","year":"2002","unstructured":"Opal, S. M. & Huber, C. E. Bench-to-bedside review: Toll-like receptors and their role in septic shock. Crit. Care 6, 125\u2013136 (2002).","journal-title":"Crit. Care"},{"key":"BFnrd914_CR27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0165-6147(94)90027-2","volume":"15","author":"GP Anderson","year":"1994","unstructured":"Anderson, G. P. & Coyle, A. J. TH2 and TH2-like cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol. Sci. 15, 324\u2013332 (1994).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrd914_CR28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","volume":"326","author":"DR Robinson","year":"1992","unstructured":"Robinson, D. R. et al. Predominant TH2-like bronchoalveolar lavage T-lymphocyte population in atopic asthma. New Engl. J. Med. 326, 298\u2013304 (1992).","journal-title":"New Engl. J. Med."},{"key":"BFnrd914_CR29","doi-asserted-by":"crossref","first-page":"B18","DOI":"10.1038\/35037014","volume":"402","author":"DB Corry","year":"1999","unstructured":"Corry, D. B. & Kheradmand, F. Induction and regulation of the IgE response. Nature 402, B18\u2013B23 (1999).","journal-title":"Nature"},{"key":"BFnrd914_CR30","doi-asserted-by":"crossref","first-page":"S547","DOI":"10.1016\/S0091-6749(00)90059-9","volume":"105","author":"LB Bacharier","year":"2000","unstructured":"Bacharier, L. B. & Geha, R. S. Molecular mechanisms of IgE regulation. J. Allergy Clin. Immunol. 105, S547\u2013S558 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd914_CR31","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","volume":"79","author":"CJ Sanderson","year":"1992","unstructured":"Sanderson, C. J. IL-5, eosinophils and disease. Blood 79, 3101\u20133109 (1992).","journal-title":"Blood"},{"key":"BFnrd914_CR32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1164\/ajrccm.161.5.9903102","volume":"161","author":"J Bousquet","year":"2000","unstructured":"Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M. & Vignola, A. M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1720\u20131745 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrd914_CR33","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/jama.1997.03550220061010","volume":"278","author":"RF Lemanske","year":"1997","unstructured":"Lemanske, R. F. & Busse, W. W. Asthma. JAMA 278, 1855\u20131873 (1997).","journal-title":"JAMA"},{"key":"BFnrd914_CR34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.immunol.17.1.255","volume":"17","author":"M Wills-Karp","year":"1999","unstructured":"Wills-Karp, M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255\u2013281 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrd914_CR35","doi-asserted-by":"crossref","first-page":"B12","DOI":"10.1038\/35037009","volume":"402","author":"PG Holt","year":"1999","unstructured":"Holt, P. G. et al. The role of allergy in the development of asthma. Nature 402, B12\u2013B17 (1999).","journal-title":"Nature"},{"key":"BFnrd914_CR36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2222.1992.tb00135.x","volume":"22","author":"PG Holt","year":"1992","unstructured":"Holt, P. G. et al. Genetic risk for atopy is associated with delayed postnatal maturation of T cell competence. Clin. Exp. Allergy 22, 1093\u20131099 (1992).","journal-title":"Clin. Exp. Allergy"},{"issue":"Suppl. 2","key":"BFnrd914_CR37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(99)90437-3","volume":"354","author":"FD Martinez","year":"1999","unstructured":"Martinez, F. D. & Holt, P. G. Role of microbial burden in aetiology of allergy and asthma. Lancet 354 (Paediatrics Suppl. 2), 12\u201315 (1999).","journal-title":"Lancet"},{"key":"BFnrd914_CR38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.320.7232.412","volume":"320","author":"PM Matricardi","year":"2000","unstructured":"Matricardi, P. M. et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiologic study. BMJ 320, 412\u2013417 (2000).","journal-title":"BMJ"},{"key":"BFnrd914_CR39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bmj.322.7283.390","volume":"322","author":"S Illi","year":"2001","unstructured":"Illi, S. et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 322, 390\u2013395 (2001).","journal-title":"BMJ"},{"key":"BFnrd914_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.275.5296.77","volume":"275","author":"T Shirakawa","year":"1997","unstructured":"Shirakawa, T., Enomoto, T., Shimazu, S. & Hopkin, J. M. The inverse association between tuberculin responses and atopic disorder. Science 275, 77\u201379 (1997).","journal-title":"Science"},{"key":"BFnrd914_CR41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1399-3003.1999.14a03.x","volume":"14","author":"E von Mutius","year":"1999","unstructured":"von Mutius, E. et al. Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children. Eur. Respir. J. 14, 4\u201311 (1999).","journal-title":"Eur. Respir. J."},{"key":"BFnrd914_CR42","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1365-2222.1999.00536.x","volume":"29","author":"K Wickens","year":"1999","unstructured":"Wickens, K., Pearce, N., Crane, J. & Beasley, R. Antibiotic use in early childhood and the development of asthma. Clin. Exp. Allergy 29, 766\u2013771 (1999).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrd914_CR43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.187.4.561","volume":"187","author":"KJ Erb","year":"1998","unstructured":"Erb, K. J., Holloway, J. W., Sobeck, A., Moll, H. & Le Gros, G. Infection of mice with Mycobacterium bovis Bacillus Calmette\u2013Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187, 561\u2013569 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnrd914_CR44","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.140.12.4245","volume":"140","author":"TF Gajewski","year":"1988","unstructured":"Gajewski, T. F. & Fitch, F. W. Anti-proliferative effect of IFN-\u03b3 in immune regulation: IFN-\u03b3 inhibits the proliferation of TH2 but not TH1 murine helper T lymphocyte clones. J. Immunol. 140, 4245\u20134252 (1988).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ni712","volume":"2","author":"M Schnare","year":"2001","unstructured":"Schnare, M. et al. Toll-like receptors control activation of adaptive immune responses. Nature Immunol. 2, 947\u2013950 (2001).This paper shows that in Myd88-deficient mice, the lack of TLR signalling leads to a T H 2 response with IgE production by default, with no induction of a T H 1 response.","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2222.1998.028s5181.x","volume":"28","author":"SL Johnston","year":"1998","unstructured":"Johnston, S. L. Mechanisms of asthma exacerbation. Clin. Exp. Allergy 28, 181\u2013186 (1998).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrd914_CR47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/bmb\/61.1.29","volume":"61","author":"SD Message","year":"2002","unstructured":"Message, S. D. & Johnston, S. L. Viruses in asthma. Br. Med. Bull. 61, 29\u201343 (2002).","journal-title":"Br. Med. Bull."},{"key":"BFnrd914_CR48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","volume":"1","author":"EA Kurt-Jones","year":"2000","unstructured":"Kurt-Jones, E. A. et al. Pattern recognition receptors TLR-4 and CD14 mediate response to respiratory syncytial virus. Nature Immunol. 1, 398\u2013401 (2000).","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00130832-200204000-00010","volume":"2","author":"AD Holla","year":"2002","unstructured":"Holla, A. D., Roy, S. R. & Liu, A. H. Endotoxin, atopy and asthma. Curr. Opin. Allergy Clin. Immunol. 2, 141\u2013145 (2002).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"BFnrd914_CR50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/thorax.57.4.328","volume":"57","author":"NG Papadopoulos","year":"2002","unstructured":"Papadopoulos, N. G., Stanciu, L. A., Papi, A., Holgate, S. T. & Johnston, S. L. A defective type 1 response to rhinovirus in atopic asthma. Thorax 57, 328\u2013332 (2002).","journal-title":"Thorax"},{"key":"BFnrd914_CR51","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.4049\/jimmunol.167.9.5067","volume":"167","author":"B Pulendran","year":"2001","unstructured":"Pulendran, B. et al. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167, 5067\u20135076 (2001).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.151.1.518","volume":"151","author":"IM Orme","year":"1993","unstructured":"Orme, I. M. et al. Cytokine secretion by CD4+ T lymphocytes aquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151, 518\u2013525 (1993).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1165\/ajrcmb.22.2.3753","volume":"22","author":"LC von Hertzen","year":"2000","unstructured":"von Hertzen, L. C. & Haahtela, T. Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response? Am. J. Respir. Cell Mol. Biol. 22, 139\u2013142 (2000).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnrd914_CR54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.275.5296.77","volume":"275","author":"T Shirakawa","year":"1997","unstructured":"Shirakawa, T. et al. The inverse association between tuberculin responses and atopic disorder. Science 275, 77\u201379 (1997).","journal-title":"Science"},{"key":"BFnrd914_CR55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.187.4.561","volume":"187","author":"KJ Erb","year":"1998","unstructured":"Erb, K. J. et al. Infection of mice with Mycobacterium bovis Bacillus Calmette\u2013Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187, 561\u2013569 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnrd914_CR56","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0091-6749(98)70030-2","volume":"102","author":"U Herz","year":"1998","unstructured":"Herz, U. et al. BCG infection suppresses allergic sensitisation and development of increased airway reactivity in an animal model. J. Allergy Clin. Immunol. 102, 867\u2013874 (1998).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd914_CR57","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1471-4906(01)02055-5","volume":"22","author":"G Wohlleben","year":"2001","unstructured":"Wohlleben, G. & Erb, K. L. Atopic disorders: a vaccine around the corner? Trends Immunol. 22, 618\u2013625 (2001).","journal-title":"Trends Immunol."},{"key":"BFnrd914_CR58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2567.1998.00432.x","volume":"93","author":"CC Wang","year":"1998","unstructured":"Wang, C. C. & Rook, G. A. Inhibition of an established allergic response to ovalbumin in Balb\/c mice by killed Mycobacterium vaccae. Immunology 93, 307\u2013313 (1998).","journal-title":"Immunology"},{"key":"BFnrd914_CR59","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000062176","volume-title":"New Drugs For Asthma, Allergy and COPD","author":"JM Hopkins","year":"2001","unstructured":"Hopkins, J. M. in New Drugs For Asthma, Allergy and COPD (eds Hansel, T. T. & Barnes, P. J.) 226\u2013228 (Karger, Basel, Switzerland, 2001)."},{"key":"BFnrd914_CR60","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1067\/mai.2001.113081","volume":"107","author":"PD Arkwright","year":"2001","unstructured":"Arkwright, P. D. & David, T. J. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J. Allergy Clin. Immunol. 107, 531\u2013534 (2001).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd914_CR61","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/ajrccm.163.6.2003050","volume":"163","author":"PM Shirtcliffe","year":"2001","unstructured":"Shirtcliffe, P. M. et al. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am. J. Respir. Crit. Care Med. 163, 1410\u20131414 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrd914_CR62","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1164\/ajrccm.163.2.2002088","volume":"163","author":"JH Park","year":"2001","unstructured":"Park, J. H., Gold, D. R., Spiegelman, D. L., Burge, H. A. & Milton, D. K. House dust endotoxin and wheeze in the first year of life. Am. J. Respir. Crit. Care Med. 163, 322\u2013328 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrd914_CR63","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0140-6736(00)02239-X","volume":"355","author":"JE Gereda","year":"2000","unstructured":"Gereda, J. E. et al. Relation between house dust endotoxin exposure, type 1 T cell development and allergen sensitiation in infants at high risk of asthma. Lancet 355, 1680\u20131683 (2000).","journal-title":"Lancet"},{"key":"BFnrd914_CR64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/09680519010070010701","volume":"7","author":"D Vercelli","year":"2001","unstructured":"Vercelli, D. et al. CD14: a bridge between innate immunity and adaptive IgE responses. J. Endotoxin Res. 7, 45\u201348 (2001).","journal-title":"J. Endotoxin Res."},{"key":"BFnrd914_CR65","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/ajrccm.163.4.2004164","volume":"163","author":"GH Koppelman","year":"2001","unstructured":"Koppelman, G. H. et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am. J. Respir. Crit. Care Med. 163, 965\u2013969 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrd914_CR66","unstructured":"Persing, D. H. et al. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds. US Patent Application WO 01\/90129 A2\/ (2002)."},{"key":"BFnrd914_CR67","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0091-6749(98)70336-7","volume":"102","author":"JE Slater","year":"1998","unstructured":"Slater, J. E. et al. Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b5. J. Allergy Clin. Immunol. 102, 977\u2013983 (1998).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd914_CR68","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","volume":"3","author":"H Hemmi","year":"2002","unstructured":"Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR-7 MyD88-dependent signaling pathway. Nature Immunol. 3, 196\u2013200 (2002).The first demonstration of synthetic low-molecular-mass compounds as TLR agonists.","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni0602-499","volume":"3","author":"M Jurk","year":"2002","unstructured":"Jurk, M. et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nature Immunol. 3, 499 (2002).","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-4632.2002.00018.x","volume":"29","author":"B Berman","year":"2002","unstructured":"Berman, B. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology. Int. J. Dermatol. 29, 7\u201311 (2002).","journal-title":"Int. J. Dermatol."},{"key":"BFnrd914_CR71","first-page":"955","volume":"72","author":"T Tokunaga","year":"1998","unstructured":"Tokunaga, T. et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterisation and antitumor activity. J. Natl Cancer Inst. 72, 955\u2013962 (1998).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrd914_CR72","first-page":"171","volume":"247","author":"HL Davis","year":"2000","unstructured":"Davis, H. L. Use of CpG DNA for enhancing specific immune responses. Curr. Top. Microbiol. Immunol. 247, 171\u2013183 (2000).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnrd914_CR73","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","volume":"93","author":"DM Klinman","year":"1996","unstructured":"Klinman, D. M. et al. CpG motifs present in bacteria DNA rapidly induce lymphocyte to secrete IL-6, IL-12, and IFN-\u03b3. Proc. Natl Acad. Sci. USA 93, 2879\u20132883 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd914_CR74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4781(99)00147-5","volume":"1489","author":"AM Krieg","year":"1999","unstructured":"Krieg, A. M. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim. Biophys. Acta 1489, 107\u2013116 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrd914_CR75","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mai.2000.107927","volume":"106","author":"H Tighe","year":"2000","unstructured":"Tighe, H. et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J. Allergy Clin. Immunol. 106, 124\u2013134 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd914_CR76","unstructured":"Lewis, A. P. & Ray, K. P. Toll-like receptor. US Patent application WO 01\/55386 A1 (2001)."},{"key":"BFnrd914_CR77","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg, A. M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709\u2013760 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrd914_CR78","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1471-4906(01)02055-5","volume":"22","author":"G Wohlleben","year":"2001","unstructured":"Wohlleben, G. & Erb, K. J. Atopic disorders: a vaccine around the corner? Trends Immunol. 22, 618\u2013625 (2001).","journal-title":"Trends Immunol."},{"key":"BFnrd914_CR79","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2567.1999.00725.x","volume":"96","author":"TC Martins","year":"1999","unstructured":"Martins, T. C. & Aguas, A. P. A role for CD45RB(low) CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes. Immunology 96, 600\u2013605 (1999).","journal-title":"Immunology"},{"key":"BFnrd914_CR80","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0952-7915(00)00162-X","volume":"12","author":"MG Roncarolo","year":"2000","unstructured":"Roncarolo, M. G. & Levings, M. K. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12, 676\u2013683 (2000).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrd914_CR81","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni0901-816","volume":"2","author":"KJ Maloy","year":"2001","unstructured":"Maloy, K. J. & Powrie, F. Regulatory T cells in the control of immune pathology. Nature Immunol. 2, 816\u2013822 (2001).","journal-title":"Nature Immunol."},{"key":"BFnrd914_CR82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm0602-625","volume":"8","author":"C Zuany-Amorim","year":"2002","unstructured":"Zuany-Amorim, C. et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T cells. Nature Med. 8, 625\u2013629 (2002).","journal-title":"Nature Med."},{"key":"BFnrd914_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","volume":"54","author":"CA Janeway Jr.","year":"1989","unstructured":"Janeway, C. A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quantit. Biol. 54, 1\u201313 (1989).","journal-title":"Cold Spring Harb. Symp. Quantit. Biol."},{"key":"BFnrd914_CR84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0167-5699(92)90198-G","volume":"13","author":"CA Janeway Jr.","year":"1992","unstructured":"Janeway, C. A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11\u201316 (1992).","journal-title":"Immunol. Today"},{"key":"BFnrd914_CR85","doi-asserted-by":"crossref","first-page":"136S","DOI":"10.1378\/chest.121.5_suppl.136S","volume":"121","author":"JA Wedzicha","year":"2002","unstructured":"Wedzicha, J. A. Exacerbations: etiology and pathophysiologic mechanisms. Chest 121, 136S\u2013141S (2002).","journal-title":"Chest"},{"key":"BFnrd914_CR86","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1053\/gast.2002.33662","volume":"122","author":"M Hausmann","year":"2002","unstructured":"Hausmann, M. et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122, 1987\u20132000 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrd914_CR87","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","volume":"169","author":"J Kim","year":"2002","unstructured":"Kim, J. et al. Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169, 1535\u20131541 (2002).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR88","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599\u2013603 (2001).","journal-title":"Nature"},{"key":"BFnrd914_CR89","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603\u2013606 (2001).References  88  and  89  show, through genetic-linkage analysis, that the LPS-binding protein NOD2 is associated with susceptibility to Crohn's disease. These data present more evidence for the involvement of PRRs in chronic inflammatory diseases.","journal-title":"Nature"},{"key":"BFnrd914_CR90","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI118861","volume":"98","author":"DJ Berg","year":"1996","unstructured":"Berg, D. J. et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with abberant cytokine production and CD4+ TH1 responses. J. Clin. Invest. 98, 1010\u20131020 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnrd914_CR91","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991\u20131045 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrd914_CR92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"P Matzinger","year":"2002","unstructured":"Matzinger, P. The danger model: a renewed sense of self. Science 296, 301\u2013305 (2002).","journal-title":"Science"},{"key":"BFnrd914_CR93","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","volume":"164","author":"K Ohashi","year":"2000","unstructured":"Ohashi, K. et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like-receptor-4 complex. J. Immunol. 164, 558\u2013561 (2000).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR94","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1074\/jbc.M111204200","volume":"277","author":"RM Vabulas","year":"2002","unstructured":"Vabulas, R. M. et al. HSP70 as endogenous stimulus of the Toll\/interleukin-1 receptor signal pathway. J. Biol. Chem. 277, 15107\u201315112 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrd914_CR95","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1074\/jbc.M200497200","volume":"277","author":"A Asea","year":"2002","unstructured":"Asea, A. et al. Novel signal transduction pathway utilised by extracellular HSP70: role of Toll-like receptor (TLR)2 and TLR4. J. Biol. Chem. 277, 15028\u201315034 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrd914_CR96","doi-asserted-by":"crossref","first-page":"16683","DOI":"10.1074\/jbc.M011695200","volume":"276","author":"JY Lee","year":"2001","unstructured":"Lee, J. Y. et al. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276, 16683\u201316689 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrd914_CR97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","volume":"195","author":"C Termeer","year":"2002","unstructured":"Termeer, C. et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor-4. J. Exp. Med. 195, 99\u2013111 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrd914_CR98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter, E. A. et al. Chromatin\u2013IgG complexes activate B-cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603\u2013607 (2002).An elegant demonstration that \u2014 in the mouse \u2014 endogenous DNA is presented to B cells by TLR-9. Includes extrapolation and discussion of the relevance of the observation to autoimmune diseases.","journal-title":"Nature"},{"key":"BFnrd914_CR99","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.4049\/jimmunol.168.12.5989","volume":"168","author":"L Guillot","year":"2002","unstructured":"Guillot, L. et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168, 5989\u20135992 (2002).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1515\/BC.2001.074","volume":"382","author":"H Singh-Jasuja","year":"2001","unstructured":"Singh-Jasuja, H. et al. The role of heat shock proteins and their receptors in the activation of the immune system. Biol. Chem. 382, 629\u2013636 (2001).","journal-title":"Biol. Chem."},{"key":"BFnrd914_CR101","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/BF02118310","volume":"48","author":"J Mollenhauer","year":"1992","unstructured":"Mollenhauer, J. & Schulmeister, A. The humoral immune response to heat shock proteins. Experientia 48, 644\u2013649 (1992).","journal-title":"Experientia"},{"key":"BFnrd914_CR102","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0049-0172(05)80028-9","volume":"22","author":"DR Schultz","year":"1993","unstructured":"Schultz, D. R. & Arnold, P. I. Heat shock (stress) proteins and autoimmunity in rheumatic diseases. Semin. Arthritis Rheum. 22, 357\u2013374 (1993).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrd914_CR103","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/hc0602.103617","volume":"105","author":"B Dybdahl","year":"2002","unstructured":"Dybdahl, B. et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through Toll-like receptor-4. Circulation 105, 685\u2013690 (2002).","journal-title":"Circulation"},{"key":"BFnrd914_CR104","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000169466","volume":"5","author":"JK Kirklin","year":"1987","unstructured":"Kirklin, J. K. et al. Cardiopulmonary bypass: studies on its damaging effects. Blood Purif. 5, 168\u2013178 (1987).","journal-title":"Blood Purif."},{"key":"BFnrd914_CR105","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/0003-4975(96)00055-0","volume":"61","author":"J Cremer","year":"1996","unstructured":"Cremer, J. et al. Systemic inflammatory response syndrome after cardiac operations. Ann. Thorac. Surg. 61, 1714\u20131720 (1996).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrd914_CR106","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S1010-7940(99)00291-2","volume":"16","author":"ON Demidov","year":"1999","unstructured":"Demidov, O. N. et al. Heat shock proteins in cardiosurgery patients. Eur. J. Cardiothorac. Surg. 16, 444\u2013449 (1999).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"BFnrd914_CR107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(01)02168-8","volume":"23","author":"RP Wallin","year":"2002","unstructured":"Wallin, R. P. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23, 130\u2013135 (2002).Extensive and critical review of heat-shock proteins and their ability to activate the innate immune response.","journal-title":"Trends Immunol."},{"key":"BFnrd914_CR108","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1096\/fj.01-0432com","volume":"15","author":"D Hwang","year":"2001","unstructured":"Hwang, D. Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through Toll-like receptor 4-derived signaling pathways. FASEB J. 15, 2556\u20132564 (2001).","journal-title":"FASEB J."},{"key":"BFnrd914_CR109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.bi.59.070190.001021","volume":"59","author":"CR Raetz","year":"1990","unstructured":"Raetz, C. R. Biochemistry of endotoxins. Annu. Rev. Biochem. 59, 129\u2013170 (1990).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnrd914_CR110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1471-4906(01)02169-X","volume":"23","author":"MG Netea","year":"2002","unstructured":"Netea, M. G. et al. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol. 23, 135\u2013139 (2002).","journal-title":"Trends Immunol."},{"key":"BFnrd914_CR111","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0891-5849(97)00098-1","volume":"23","author":"UM Agren","year":"1997","unstructured":"Agren, U. M. et al. Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic. Biol. Med. 23, 996\u20131001 (1997).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrd914_CR112","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-5193(86)80076-5","volume":"119","author":"PH Weigel","year":"1986","unstructured":"Weigel, P. H. et al. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J. Theor. Biol. 119, 219\u2013234 (1986).","journal-title":"J. Theor. Biol."},{"key":"BFnrd914_CR113","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1096\/fasebj.6.7.1563592","volume":"6","author":"TC Laurent","year":"1992","unstructured":"Laurent, T. C. & Fraser, J. R. Hyaluronan. FASEB J. 6, 2397\u20132404 (1992).","journal-title":"FASEB J."},{"key":"BFnrd914_CR114","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1084\/jem.183.5.2373","volume":"183","author":"PW Noble","year":"1996","unstructured":"Noble, P. W. et al. Hyaluronan fragments activate an NF-\u03baB\/I-\u03baB auto-regulatory loop in murine macrophages. J. Exp. Med. 183, 2373\u20132378 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnrd914_CR115","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.4049\/jimmunol.165.4.1863","volume":"165","author":"CJ Termeer","year":"2000","unstructured":"Termeer, C. J. et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165, 1863\u20131870 (2000).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR116","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","volume":"44","author":"E Tan","year":"1989","unstructured":"Tan, E. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44, 93\u2013151 (1989).","journal-title":"Adv. Immunol."},{"key":"BFnrd914_CR117","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4049\/jimmunol.165.3.1626","volume":"165","author":"IR Rifkin","year":"2000","unstructured":"Rifkin, I. R. et al. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J. Immunol. 165, 1626\u20131633 (2000).","journal-title":"J. Immunol."},{"key":"BFnrd914_CR118","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/328805a0","volume":"328","author":"MJ Shlomchik","year":"1987","unstructured":"Shlomchik, M. J. et al. The role of clonal selection and somatic mutation in autoimmunity. Nature 328, 805\u2013811 (1987).","journal-title":"Nature"},{"key":"BFnrd914_CR119","doi-asserted-by":"crossref","unstructured":"The Canadian Hydroxychloroqine Study Group. A randomised study on the effect of withdrawing hydroxychloroquine in systemic lupus erythematosus. N. Engl. J. Med. 324, 150\u2013154 (1991).","DOI":"10.1056\/NEJM199101173240303"}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrd914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd914","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:27:43Z","timestamp":1744284463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,1]]},"references-count":119,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10,1]]}},"alternative-id":["BFnrd914"],"URL":"https:\/\/doi.org\/10.1038\/nrd914","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,1]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}